About Ganymed Pharmaceuticals
Ganymed Pharmaceuticals is a company based in Mainz (Germany) founded in 2001 was acquired by Astellas Pharma in December 2016.. Ganymed Pharmaceuticals has raised $212.06 million across 6 funding rounds from investors including Astellas Pharma, Landesbank Baden Wurttemberg and KfW. The company has 4 employees as of March 31, 2019. Ganymed Pharmaceuticals offers products and services including Sports Betting, Casino Games, Poker, and Slot Games. Ganymed Pharmaceuticals operates in a competitive market with competitors including BeiGene, Moderna, Denali Therapeutics, Incyte and MiRagen, among others.
- Headquarter Mainz, Germany
- Employees 4 as on 31 Mar, 2019
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ganymed Pharmaceuticals Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$212.06 M (USD)
in 6 rounds
-
Latest Funding Round
$57.35 M (USD), Series E
Nov 18, 2013
-
Investors
Astellas Pharma
& 10 more
-
Employee Count
4
as on Mar 31, 2019
-
Acquired by
Astellas Pharma
(Dec 21, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ganymed Pharmaceuticals
Ganymed Pharmaceuticals offers a comprehensive portfolio of products and services, including Sports Betting, Casino Games, Poker, and Slot Games. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for wagering on sports events like football and basketball.
Online casino offering blackjack, roulette, and baccarat games.
Varied poker tournaments for players of all levels.
Digital slots with themes and jackpot features.
Funding Insights of Ganymed Pharmaceuticals
Ganymed Pharmaceuticals has successfully raised a total of $212.06M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $57.35 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series E — $57.3M
-
First Round
First Round
(01 Jun 2002)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2013 | Amount | Series E - Ganymed Pharmaceuticals | Valuation |
investors |
|
| Nov, 2008 | Amount | Series D - Ganymed Pharmaceuticals | Valuation |
investors |
|
| Apr, 2007 | Amount | Series C - Ganymed Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ganymed Pharmaceuticals
Ganymed Pharmaceuticals has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Astellas Pharma, Landesbank Baden Wurttemberg and KfW. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC Firm funding companies in Europe
|
Founded Year | Domain | Location | |
|
Early-stage VC firm investing in smart & deep-tech, fin-tech and life science & health-tech sectors
|
Founded Year | Domain | Location | |
|
Financial services, investment management, and capital allocation in various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ganymed Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ganymed Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ganymed Pharmaceuticals Comparisons
Competitors of Ganymed Pharmaceuticals
Ganymed Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Denali Therapeutics, Incyte and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
ALX Oncology is focused on advancing cancer treatment therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ganymed Pharmaceuticals
Frequently Asked Questions about Ganymed Pharmaceuticals
When was Ganymed Pharmaceuticals founded?
Ganymed Pharmaceuticals was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Where is Ganymed Pharmaceuticals located?
Ganymed Pharmaceuticals is headquartered in Mainz, Germany. It is registered at Mainz, Rhineland-palatinate, Germany.
Is Ganymed Pharmaceuticals a funded company?
Ganymed Pharmaceuticals is a funded company, having raised a total of $212.06M across 6 funding rounds to date. The company's 1st funding round was a Series C of $45.5M, raised on Jun 01, 2002.
How many employees does Ganymed Pharmaceuticals have?
As of Mar 31, 2019, the latest employee count at Ganymed Pharmaceuticals is 4.
What does Ganymed Pharmaceuticals do?
Founded in 2001 and based in Mainz, Germany, antibody-based therapeutics for solid tumors are developed. Focus is placed on oncology drugs such as IMAB362, targeted at gastroesophageal cancer, and IMAB027, directed toward ovarian cancer. Discovery efforts address breast cancer and other solid tumors. Additionally, Claudetect18.2, a CE-marked in vitro diagnostic, is provided to evaluate claudin-18.2 expression in gastroesophageal, pancreatic, lung, and related cancers.
Who are the top competitors of Ganymed Pharmaceuticals?
Ganymed Pharmaceuticals's top competitors include Moderna, BeiGene and Strand Therapeutics.
What products or services does Ganymed Pharmaceuticals offer?
Ganymed Pharmaceuticals offers Sports Betting, Casino Games, Poker, and Slot Games.
Who are Ganymed Pharmaceuticals's investors?
Ganymed Pharmaceuticals has 11 investors. Key investors include Astellas Pharma, Landesbank Baden Wurttemberg, KfW, MIG Capital, and LBBW Venture Capital.